$383 Million is the total value of Ghost Tree Capital, LLC's 39 reported holdings in Q1 2019. The portfolio turnover from Q4 2018 to Q1 2019 was 130.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ASND | Buy | ASCENDIS PHARMA A Ssponsored adr | $45,315,000 | +478.7% | 385,000 | +208.0% | 11.84% | +316.6% |
| ACAD | Buy | ACADIA PHARMACEUTICALS INC | $24,165,000 | +1095.7% | 900,000 | +620.0% | 6.31% | +761.3% |
| ASND | New | ASCENDIS PHARMA A Sput | $21,775,000 | – | 185,000 | +100.0% | 5.69% | – |
| BPMC | New | BLUEPRINT MEDICINES CORP | $19,212,000 | – | 240,000 | +100.0% | 5.02% | – |
| FOLD | Buy | AMICUS THERAPEUTICS INC | $17,680,000 | +183.9% | 1,300,000 | +100.0% | 4.62% | +104.4% |
| GBT | Buy | GLOBAL BLOOD THERAPEUTICS IN | $15,879,000 | +286.8% | 300,000 | +200.0% | 4.15% | +178.5% |
| ALNY | Buy | ALNYLAM PHARMACEUTICALS INC | $14,018,000 | +449.3% | 150,000 | +328.6% | 3.66% | +295.5% |
| SAGE | Buy | SAGE THERAPEUTICS INC | $11,929,000 | +3675.0% | 75,000 | +2172.7% | 3.12% | +2610.4% |
| IOVA | Buy | IOVANCE BIOTHERAPEUTICS INC | $10,937,000 | +23.6% | 1,150,000 | +15.0% | 2.86% | -11.1% |
| CBAY | New | CYMABAY THERAPEUTICS INC | $9,960,000 | – | 750,000 | +100.0% | 2.60% | – |
| BHVN | New | BIOHAVEN PHARMACTL HLDG CO Lcall | $9,007,000 | – | 175,000 | +100.0% | 2.35% | – |
| PTGX | New | PROTAGONIST THERAPEUTICS INC | $8,799,000 | – | 700,000 | +100.0% | 2.30% | – |
| FXF | Buy | INVESCO CURNCYSHS SWISS FRANswiss franc | $8,574,000 | +63.7% | 91,800 | +66.3% | 2.24% | +17.8% |
| MNTA | Buy | MOMENTA PHARMACEUTICALS INC | $7,265,000 | +102.5% | 500,000 | +53.8% | 1.90% | +45.8% |
| RARX | New | RA PHARMACEUTICALS INC | $6,720,000 | – | 300,000 | +100.0% | 1.76% | – |
| DBVT | New | DBV TECHNOLOGIES S Asponsored adr | $6,554,000 | – | 850,000 | +100.0% | 1.71% | – |
| EPZM | New | EPIZYME INC | $6,195,000 | – | 500,000 | +100.0% | 1.62% | – |
| CHRS | New | COHERUS BIOSCIENCES INC | $6,138,000 | – | 450,000 | +100.0% | 1.60% | – |
| KDMN | Buy | KADMON HLDGS INC | $5,544,000 | +33.3% | 2,100,000 | +5.0% | 1.45% | -4.1% |
| AXSM | New | AXSOME THERAPEUTICS INC | $4,411,000 | – | 310,000 | +100.0% | 1.15% | – |
| CHMA | New | CHIASMA INC | $3,640,000 | – | 700,000 | +100.0% | 0.95% | – |
| SLDB | New | SOLID BIOSCIENCES INC | $920,000 | – | 100,000 | +100.0% | 0.24% | – |
| FGEN | New | FIBROGEN INC | $625,000 | – | 11,500 | +100.0% | 0.16% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2020-04-09
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MIRATI THERAPEUTICS INC | 30 | Q3 2023 | 7.3% |
| ASCENDIS PHARMA A/S - ADR | 28 | Q3 2023 | 11.8% |
| BIOCRYST PHARMACEUTICALS INC | 25 | Q2 2023 | 2.4% |
| AMICUS THERAPEUTICS INC | 23 | Q3 2023 | 5.6% |
| SAREPTA THERAPEUTICS INC | 22 | Q3 2023 | 9.1% |
| SPDR SER TR | 20 | Q3 2022 | 16.9% |
| IOVANCE BIOTHERAPEUTICS INC | 18 | Q2 2023 | 5.5% |
| ROCKET PHARMACEUTICALS INC | 18 | Q2 2023 | 6.1% |
| SAGE THERAPEUTICS INC | 18 | Q1 2021 | 4.8% |
| IMMUNOMEDICS INC | 17 | Q2 2020 | 8.7% |
View Ghost Tree Capital, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-16 |
View Ghost Tree Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.